Overcoming Challenges Facing Advanced Therapies in the EU Market
- 1 September 2016
- journal article
- Published by Elsevier in Cell Stem Cell
- Vol. 19 (3), 293-297
- https://doi.org/10.1016/j.stem.2016.08.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Putting a price tag on novel autologous cellular therapiesCytotherapy, 2016
- Gene Therapies: The Challenge of sUper-High-Cost Treatments and How to Pay for themRegenerative Medicine, 2016
- Commercialization of cellular immunotherapies for cancerBiochemical Society Transactions, 2016
- Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 CountriesPLOS ONE, 2015
- Stem Cell Therapies in Clinical Trials: Progress and ChallengesCell Stem Cell, 2015
- Gene therapy: a possible future standard for HIV careTrends in Biotechnology, 2015
- Therapeutic cancer vaccine survives biotech bustNature, 2015
- The business case for cell and gene therapiesNature Biotechnology, 2014
- A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIVTrends in Molecular Medicine, 2014
- The Impact of Market Volatility on the Cell Therapy IndustryCell Stem Cell, 2011